comprehensive -WSS

comprehensive

author：comprehensive 2025-08-11 16:24:37 - browse：246

Principal Deputy FDA Commissioner Janet Woodcock Stefani Reynolds/The New York Times via AP

WASHINGTON — Principal Deputy FDA Commissioner Janet Woodcock will retire early next year from the Food and Drug Administration after helping steer the agency through an historic period of medical advances during nearly four decades in key leadership positions, she confirmed to STAT Thursday.

Woodcock, a doctor with a chemistry degree, joined FDA in 1986 at its biologics center, where she oversaw the approval of the first biotechnology-based treatments for multiple sclerosis and cystic fibrosis. In 1994, she was named director of the drug center, where she played a key role in guiding some of the most impactful changes to the regulation of medicine, according to Trump administration FDA Commissioner Scott Gottlieb.

Woodcock envisioned that antibody drugs would become a backbone of therapy and created a more predictable regulatory path for their review and approval, Gottlieb said. She presided over a major expansion and modernization of the generic drug program, standardizing reviews in a way that allowed the industry to become safer and more robust, and crafted the reform of over-the-counter drug reviews.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Hospitals are piloting generative AI tools as regulators play catch

WSS

Do masks work? RCTs can't tell us

In 'major milestone,' FDA approves first cell therapy for solid tumors

#NeedHerScience: shining a light on gender disparities in medicine

As AI regulations shape up, health tech startups beg for clarity

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

The battle over the Brookhaven Landfill on Long Island

Wikipedia

comprehensive

hotspot

Virginia high school admissions case could be legal follow

New study raises questions about niacin and heart health

In age of alternative facts, a scholarly course on calling out crap

WATCH: Why do our ears pop?

Jerome Adams on the need for new antivirals for Covid

Hospitals are piloting generative AI tools as regulators play catch

Medical leaders decry Supreme Court decision on affirmative action

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

Sports medicine is finally prioritizing gender equality

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

hotspot

Hospitals are piloting generative AI tools as regulators play catch

Paxlovid study fails to answer questions over benefit for broader groups

Opioid cravings were reduced by anti

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

3 hurdles to bringing medical devices to the U.S. market

Measles policy set amid Florida outbreak alarms vaccine proponents

leisure time

focus

Wikipedia

hotspot